HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
93.06
+1.58 (1.73%)
At close: Sep 8, 2025, 4:00 PM
93.49
+0.43 (0.46%)
After-hours: Sep 8, 2025, 7:08 PM EDT
HealthEquity Stock Forecast
Stock Price Forecast
The 15 analysts that cover HealthEquity stock have a consensus rating of "Strong Buy" and an average price target of $118.6, which forecasts a 27.44% increase in the stock price over the next year. The lowest target is $100 and the highest is $134.
Price Target: $118.6 (+27.44%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HealthEquity stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 7 | 8 | 7 | 7 | 8 | 9 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 13 | 13 | 14 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $130 → $134 | Strong Buy | Maintains | $130 → $134 | +43.99% | Sep 3, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $125 → $126 | Buy | Maintains | $125 → $126 | +35.40% | Sep 3, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $125 | Buy | Maintains | $125 | +34.32% | Sep 3, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $109 → $110 | Buy | Maintains | $109 → $110 | +18.20% | Sep 3, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $125 | Buy | Maintains | $125 | +34.32% | Aug 29, 2025 |
Financial Forecast
Revenue This Year
1.32B
from 1.20B
Increased by 9.69%
Revenue Next Year
1.43B
from 1.32B
Increased by 8.89%
EPS This Year
3.75
from 1.09
Increased by 244.23%
EPS Next Year
4.45
from 3.75
Increased by 18.52%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | 1.5B | |
| Avg | 1.3B | 1.4B | |
| Low | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.0% | 16.6% | |
| Avg | 9.7% | 8.9% | |
| Low | 5.9% | 4.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.97 | 4.78 | |
| Avg | 3.75 | 4.45 | |
| Low | 3.56 | 4.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 264.1% | 27.3% | |
| Avg | 244.2% | 18.5% | |
| Low | 226.4% | 11.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.